TY - JOUR
T1 - Uterus transplantation
T2 - Toward clinical application in Japan
AU - Suganuma, Nobuhiko
AU - Hayashi, Ayako
AU - Kisu, Iori
AU - Banno, Kouji
AU - Hara, Hisako
AU - Mihara, Makoto
N1 - Funding Information:
Parts of this manuscript were presented as “overviews” at symposia entitled “Present situation of UTx” at the IFFS/JSRM International Meeting 2015 (April 26-29, 2015, Yokohama, Japan) and “Treatment for women with UFI in our country: UTx vs surrogacy” at The 61st Congress of Japan Society for Reproductive Medicine (November 3-4, 2016, Yokohama, Japan). This work was partially supported by a Japan Society for the Promotion of Science KAKENHI Grant No. 15K15852, Tokyo, Japan. We would like to thank Editage for English-language editing.
Publisher Copyright:
© 2017 The Authors. Reproductive Medicine and Biology published by John Wiley & Sons Australia, Ltd on behalf of Japan Society for Reproductive Medicine.
PY - 2017/10
Y1 - 2017/10
N2 - Background: In recent years, uterus transplantation (UTx) has been applied as the treatment for patients with uterine factor infertility worldwide. Thus, the clinical application of UTx in Japan should be considered through both the history of UTx technology development in the world and future prospects. Methods: Recent information on UTx was collected via a literature survey and the Internet. Results: Basic research using various animals has been done mainly since 2000. In 2014, the world's first UTx baby was born in Sweden. In total, 24 UTx procedures have been performed at 10 institutes in nine countries and five births were obtained (as of May, 2017). In Japan, the “Project Team for Uterus Transplantation” initiated UTx experiments in 2008 and the “Japan Society for Uterus Transplantation” was organized in March, 2014. In the rest of the world, the “International Society for Uterus Transplantation” was established in January, 2016. Conclusion: Uterus transplantation is still under development as a reproductive medicine tool and organ transplant procedure. A collaborative system that is not limited by facilities and specialties should strive to build an “all-Japan” team.
AB - Background: In recent years, uterus transplantation (UTx) has been applied as the treatment for patients with uterine factor infertility worldwide. Thus, the clinical application of UTx in Japan should be considered through both the history of UTx technology development in the world and future prospects. Methods: Recent information on UTx was collected via a literature survey and the Internet. Results: Basic research using various animals has been done mainly since 2000. In 2014, the world's first UTx baby was born in Sweden. In total, 24 UTx procedures have been performed at 10 institutes in nine countries and five births were obtained (as of May, 2017). In Japan, the “Project Team for Uterus Transplantation” initiated UTx experiments in 2008 and the “Japan Society for Uterus Transplantation” was organized in March, 2014. In the rest of the world, the “International Society for Uterus Transplantation” was established in January, 2016. Conclusion: Uterus transplantation is still under development as a reproductive medicine tool and organ transplant procedure. A collaborative system that is not limited by facilities and specialties should strive to build an “all-Japan” team.
KW - Mayer–Rokitansky–Küster–Hauser syndrome
KW - ethical issues
KW - surrogacy
KW - uterine factor infertility
KW - uterus transplantation
UR - http://www.scopus.com/inward/record.url?scp=85026798221&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85026798221&partnerID=8YFLogxK
U2 - 10.1002/rmb2.12048
DO - 10.1002/rmb2.12048
M3 - Review article
AN - SCOPUS:85026798221
SN - 1445-5781
VL - 16
SP - 305
EP - 313
JO - Reproductive Medicine and Biology
JF - Reproductive Medicine and Biology
IS - 4
ER -